Ratings by Leerink (Danielle Antalffy)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/27/2022 | Edwards Lifesciences | EW | Maintain | Outperform (N/A) |
|
Details | ||
| 7/15/2021 | Shockwave Medical | SWAV | New Coverage | Outperform (N/A) |
171.63 (334.75) |
95.04% | Details | |
| 6/2/2021 | Abbott Labs | ABT | Maintain | Market Perform (N/A) |
|
Details | ||
| 5/17/2021 | NeuroPace Inc | NPCE | New Coverage | Outperform (N/A) |
20.91 (15.92) |
-23.86% | Details | |
| 4/20/2021 | CytoSorbents | CTSO | Maintain | Outperform (N/A) |
|
Details | ||
| 4/1/2021 | Insulet Corporation | PODD | Upgrade | Outperform (Market Perform) |
260.92 (143.90) |
-44.85% | Details | |
| 4/1/2021 | Senseonics Holdings | SENS | Downgrade | Market Perform (Outperform) |
2.64 (6.26) |
137.12% | Details | |
| 2/25/2021 | Inogen, Inc | INGN | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/25/2021 | Vericel Corporation | VCEL | Maintain | Outperform (N/A) |
|
Details | ||
| 1/19/2021 | Nevro Corp | NVRO | Maintain | Outperform (N/A) |
|
Details | ||
| 12/21/2020 | ABIOMED | ABMD | Maintain | Market Perform (N/A) |
|
Details | ||
| 12/14/2020 | Cardiovascular Systems | CSII | Maintain | Outperform (N/A) |
|
Details | ||
| 12/14/2020 | AtriCure Inc. | ATRC | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2020 | Neovasc | NVCN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/12/2020 | Outset Medical Inc. | OM | New Coverage | Outperform (N/A) |
42.51 (4.76) |
-88.8% | Details | |
| 9/28/2020 | Inari Medical Inc. | NARI | New Coverage | Outperform (N/A) |
64.60 (79.97) |
23.79% | Details | |
| 9/1/2020 | CytoSorbents | CTSO | New Coverage | Outperform (N/A) |
8.44 (0.43) |
-94.91% | Details | |
| 8/7/2020 | ABIOMED | ABMD | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/6/2020 | Silk Road Medical | SILK | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2020 | Nevro Corp | NVRO | Maintain | Outperform (N/A) |
|
Details | ||
| 7/31/2020 | Tandem Diabetes Care | TNDM | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/30/2020 | Boston Scientific | BSX | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/29/2020 | DexCom | DXCM | Maintain | Outperform (N/A) |
|
Details | ||
| 7/29/2020 | AtriCure Inc. | ATRC | Maintain | Outperform (N/A) |
|
Details | ||
| 7/24/2020 | Edwards Lifesciences | EW | Maintain | Outperform (N/A) |
|
Details | ||
| 7/9/2020 | Silk Road Medical | SILK | New Coverage | Outperform (N/A) |
44.62 (27.49) |
-38.39% | Details | |
| 6/1/2020 | Inogen, Inc | INGN | Maintain | Market Perform (N/A) |
|
Details | ||
| 4/29/2020 | DexCom | DXCM | Maintain | Outperform (N/A) |
|
Details | ||
| 4/27/2020 | ABIOMED | ABMD | Downgrade | Market Perform (Outperform) |
168.52 (381.02) |
126.1% | Details | |
| 4/24/2020 | Tandem Diabetes Care | TNDM | Downgrade | Market Perform (Outperform) |
75.40 (14.41) |
-80.89% | Details | |
| 4/24/2020 | Insulet Corporation | PODD | Downgrade | Market Perform (Outperform) |
206.16 (143.90) |
-30.2% | Details | |
| 4/22/2020 | Boston Scientific | BSX | Downgrade | Market Perform (Outperform) |
35.05 (45.60) |
30.1% | Details | |
| 4/17/2020 | Edwards Lifesciences | EW | Upgrade | Outperform (Market Perform) |
217.52 (86.95) |
-60.03% | Details | |
| 2/7/2020 | ABIOMED | ABMD | Maintain | Outperform (N/A) |
|
Details | ||
| 1/23/2020 | Johnson & Johnson | JNJ | Maintain | Outperform (N/A) |
|
Details | ||
| 1/23/2020 | Abbott Labs | ABT | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/8/2019 | DexCom | DXCM | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2019 | Inogen, Inc | INGN | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/5/2019 | Tandem Diabetes Care | TNDM | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/1/2019 | ABIOMED | ABMD | Maintain | Outperform (N/A) |
|
Details | ||
| 10/14/2019 | Vericel Corporation | VCEL | Maintain | Outperform (N/A) |
|
Details | ||
| 10/14/2019 | Tandem Diabetes Care | TNDM | Maintain | Outperform (N/A) |
|
Details | ||
| 10/14/2019 | Senseonics Holdings | SENS | Maintain | Outperform (N/A) |
|
Details | ||
| 10/14/2019 | Nevro Corp | NVRO | Maintain | Outperform (N/A) |
|
Details | ||
| 10/14/2019 | Edwards Lifesciences | EW | Maintain | Market Perform (N/A) |
|
Details | ||
| 10/14/2019 | DexCom | DXCM | Maintain | Outperform (N/A) |
|
Details | ||
| 9/24/2019 | Insulet Corporation | PODD | Maintain | Outperform (N/A) |
|
Details | ||
| 8/23/2019 | Nevro Corp | NVRO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/13/2019 | Avedro | AVDR | Downgrade | Market Perform (Outperform) |
23.07 (24.26) |
5.16% | Details | |
| 8/8/2019 | Inogen, Inc | INGN | Downgrade | Market Perform (Outperform) |
42.32 (6.54) |
-84.55% | Details | |
| 8/7/2019 | Cardiovascular Systems | CSII | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2019 | Insulet Corporation | PODD | Maintain | Outperform (N/A) |
|
Details | ||
| 7/31/2019 | Boston Scientific | BSX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2019 | Tandem Diabetes Care | TNDM | New Coverage | Outperform (N/A) |
64.42 (14.41) |
-77.63% | Details | |
| 3/11/2019 | Avedro | AVDR | New Coverage | Outperform (N/A) |
11.69 (23.07) |
97.35% | Details | |
| 11/6/2018 | Vericel Corporation | VCEL | Maintain | Outperform (N/A) |
|
Details | ||
| 11/1/2018 | Baxter International | BAX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/3/2018 | Neovasc | NVCN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/5/2018 | Vericel Corporation | VCEL | Maintain | Outperform (N/A) |
|
Details | ||
| 8/22/2018 | DexCom | DXCM | Maintain | Outperform (N/A) |
|
Details |
